---
figid: PMC2949647__bcr2617-1
figlink: /pmc/articles/PMC2949647/figure/F1/
number: Figure 1
caption: Structure and signaling machinery of the Met receptor. Met is an α/β heterodimer
  formed by a completely extracellular α subunit and a transmembrane β subunit that
  contains the tyrosine kinase activity. The extracellular region of Met encompasses
  a large Sema domain - which spans the α subunit and part of the β subunit, folding
  into a β-propeller structure - a cysteine-rich domain and four repeats of an unusual
  type of immunoglobulin-like domain. The intracellular portion of Met includes the
  kinase domain - with two catalytic tyrosines (Tyr1234 and Tyr1235) that enhance
  the receptor enzymatic activity following transphosphorylation - and key tyrosine
  residues in the carboxy-terminal tail (Tyr1349 and Tyr1356). Phosphorylation of
  these distal tyrosines creates docking sites for several interactors, many of which
  are schematized here. Recruitment of these signaling effectors activates downstream
  pathways that together enable biological execution of the invasive growth process.
  The Ras-Erk/mitogen-activated protein kinase (MAPK) cascade launches a program of
  transcriptional modulation that involves changes in the expression of cell-cycle
  regulators and extracellular matrix proteinases. Ras also stimulates the Rac1/Cdc42-PAK
  pathway, which, together with the Gab1-Crk-C3G-Rap1 axis, regulates the activity
  of cytoskeletal and adhesion molecules such as cadherins, Arp, N-WASP, paxillin,
  integrins and focal adhesion kinase. The Gab1-phosphoinositide 3-kinase (PI3K)-Akt
  pathway encourages cell survival by inhibiting the proapoptotic molecule Bad and
  the apopototic effector caspase 9.
pmcid: PMC2949647
papertitle: 'The Met oncogene and basal-like breast cancer: another culprit to watch
  out for?.'
reftext: Stefania Gastaldi, et al. Breast Cancer Res. 2010;12(4):208-208.
pmc_ranked_result_index: '103371'
pathway_score: 0.9544797
filename: bcr2617-1.jpg
figtitle: Structure and signaling machinery of the Met receptor
year: '2010'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2949647__bcr2617-1.html
  '@type': Dataset
  description: Structure and signaling machinery of the Met receptor. Met is an α/β
    heterodimer formed by a completely extracellular α subunit and a transmembrane
    β subunit that contains the tyrosine kinase activity. The extracellular region
    of Met encompasses a large Sema domain - which spans the α subunit and part of
    the β subunit, folding into a β-propeller structure - a cysteine-rich domain and
    four repeats of an unusual type of immunoglobulin-like domain. The intracellular
    portion of Met includes the kinase domain - with two catalytic tyrosines (Tyr1234
    and Tyr1235) that enhance the receptor enzymatic activity following transphosphorylation
    - and key tyrosine residues in the carboxy-terminal tail (Tyr1349 and Tyr1356).
    Phosphorylation of these distal tyrosines creates docking sites for several interactors,
    many of which are schematized here. Recruitment of these signaling effectors activates
    downstream pathways that together enable biological execution of the invasive
    growth process. The Ras-Erk/mitogen-activated protein kinase (MAPK) cascade launches
    a program of transcriptional modulation that involves changes in the expression
    of cell-cycle regulators and extracellular matrix proteinases. Ras also stimulates
    the Rac1/Cdc42-PAK pathway, which, together with the Gab1-Crk-C3G-Rap1 axis, regulates
    the activity of cytoskeletal and adhesion molecules such as cadherins, Arp, N-WASP,
    paxillin, integrins and focal adhesion kinase. The Gab1-phosphoinositide 3-kinase
    (PI3K)-Akt pathway encourages cell survival by inhibiting the proapoptotic molecule
    Bad and the apopototic effector caspase 9.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK11
  - PAK2
  - MAPK3
  - PIK3CD
  - PAK6
  - PAK3
  - PTPN11
  - MAPK8
  - PIK3CG
  - MAPK1
  - PAK5
  - PIK3CB
  - NRAS
  - FOSL1
  - SART3
  - MAPK14
  - MAPK9
  - RHOG
  - PIK3CA
  - HRAS
  - GAB1
  - PAK1
  - CDC42
  - CRK
  - KRAS
  - JUND
  - PIK3R3
  - PIK3R6
  - JUNB
  - PAK4
  - GRB2
  - TERF2IP
  - MAPK10
  - ETS1
  - FOSB
  - JUN
  - BRAF
  - FOS
  - SOS2
  - FOSL2
  - AKT3
  - MAPK12
  - PIK3R4
  - SOS1
  - RAC2
  - AKT1
  - AKT2
  - RAC1
  - RAF1
  - MAPK13
  - PIK3R5
  - ARAF
  - RAC3
  - Cancer
  - Noonan syndrome
genes:
- word: Erk/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Pak
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK2
  entrez: '5062'
- word: Erk/MAPK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Pak
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK6
  entrez: '56924'
- word: Pak
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK3
  entrez: '5063'
- word: Shp2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: Erk/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Erk/MAPK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Pak
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK5
  entrez: '57144'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AP1.
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: Erk/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Erk/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Erk/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: GAB1
  symbol: GAB1
  source: hgnc_symbol
  hgnc_symbol: GAB1
  entrez: '2549'
- word: Pak
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: Cdc42
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: Crk
  symbol: CRK
  source: hgnc_symbol
  hgnc_symbol: CRK
  entrez: '1398'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AP1.
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AP1.
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: Pak
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK4
  entrez: '10298'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Rap1
  symbol: RAP1
  source: hgnc_alias_symbol
  hgnc_symbol: TERF2IP
  entrez: '54386'
- word: Erk/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Ets1,
  symbol: ETS1
  source: hgnc_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: AP1.
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP1.
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AP1.
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: Erk/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: AP1.
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Erk/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Erk/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
